As of 2024-12-11, the Relative Valuation of Brooklyn Immunotherapeutics Inc (BTX) is (2.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.21 USD, the upside of Brooklyn Immunotherapeutics Inc based on Relative Valuation is -1265.4%.
The range of the Relative Valuation is (2.53) - (2.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 41.1x - 52.8x | 46.0x |
| Forward P/E multiples | 31.2x - 36.0x | 31.7x |
| Fair Price | (2.53) - (2.21) | (2.39) |
| Upside | -1332.9% - -1178.7% | -1265.4% |
| Date | P/E |